$INFU News

InfuSystem Holdings Approves New $20M Stock Buyback Program, Replacing Expiring Repurchase Authorization

InfuSystem Elects Beverly Huss Board Chairman

InfuSystem Holdings, Inc. (INFU) Shareholder/Analyst Call Prepared Remarks Transcript

InfuSystem Holdings, Inc. (INFU) Q1 2026 Earnings Call Transcript

INFU Reports Mixed Q1 2026 Results: Revenue Misses Estimates, Earnings Beat on Strategic Restructuring INFUSYSTEM HOLDINGS INC (NYSEARCA:INFU)

InfuSystem Reiterated FY26 Pro-forma Net Revenue Growth Of 6%-8% YoY

InfuSystem: Expecting Strong Stock Gains In 2026

InfuSystems Holdings Inc (INFU) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and ...

Roth Capital Reiterates Buy on InfuSystems Holdings, Raises Price Target to $15

InfuSystems Holdings, Inc. (INFU) Q4 Earnings Beat Estimates

InfuSystem Holdings Inc (INFU) Reports Strong Earnings Beat and Margin Expansion in Q4 2025

InfuSystem Holdings, Inc. (INFU) Q4 2025 Earnings Call Transcript

InfuSystems Holdings Forecasts 6%–8% Pro-Forma Revenue Growth for 2026 Despite $7.1M Contract Impact

InfuSystems Holdings Q4 Earnings Assessment

InfuSystems Holdings Q4 EPS $0.10 Beats $0.07 Estimate, Sales $36.230M Miss $36.677M Estimate

InfuSystems Holdings Q4 EPS $0.10 Beats $0.07 Estimate, Sales $36.230M Miss $36.677M Estimate

InfuSystem: Regulatory Backed Market Catalyst

Ambulatory Infusion Pumps used in Pain Management Business by InfuSystem to Receive Separate Payment Under NOPAIN Act Starting January 1, 2026

InfuSystem Pain Management Infusion Pumps To Receive Separate Medicare Payment Under NOPAIN Act Starting January 1, 2026

InfuSystem Stock: Margin Expansion And Growth Strategy To Drive Strong Gains